And such interventions are not risk-free.
Such interventions are likely to prove a gruelling experience for clinical commissioning groups (CCGs).
However, robust data demonstrating effectiveness of such interventions are lacking.
Robust evaluations of such interventions are urgently required.
In one sense, such interventions are in line with the mission set by the Caisse's founding fathers.
The F.D.A. says such interventions are necessary when companies make health claims that may endanger the public health, even unintentionally.
But to get to the stage where such interventions are feasible will require a huge research commitment.
Many objections to germline interventions emphasise that such interventions are objectionable in that they affect "generations down the line".
Unfortunately, such interventions are often resisted and rarely produce significant gains.
Such interventions are being developed and tested for children as young as the preschool years.
While such interventions are possible for laboratory operations, limiting the impact on wild fisheries is a much greater challenge.
